Clinical Trials Logo

Clinical Trial Details — Status: Completed

Administrative data

NCT number NCT00940277
Other study ID # CA-65727
Secondary ID R01CA078084-07IR
Status Completed
Phase N/A
First received July 14, 2009
Last updated February 2, 2016
Start date December 2007
Est. completion date October 2015

Study information

Verified date February 2016
Source Fox Chase Cancer Center
Contact n/a
Is FDA regulated No
Health authority United States: Institutional Review BoardUnited States: Federal Government
Study type Interventional

Clinical Trial Summary

The goal of the proposed study is to evaluate the efficacy of 2 couple-focused interventions developed to reduce the psychological distress on women and their partners during and after the breast cancer experience. The first group, an Enhanced Couple-Focused Group (ECG), incorporates cognitive-behavioral interventions (e.g., relaxation, stress management skills) as well as basic relationship communication and support skills (e.g., expressing support needs constructively). The second group, a Couples' Support Group (SG), is a non-structured group where general topics are discussed. The investigators will evaluate the impact of each group condition on patients' psychological adaptation, social and role functioning, and cancer treatment adherence. The investigators will also evaluate whether patient and partner perceptions of relationship support, relationship intimacy, stress management skills, and intervention group support mediate the groups' effects on each other's psychological adaptation.

The investigators hypothesize that ECG will have stronger positive effects on patient general and cancer-related distress and well-being than SG.

The investigators hypothesize that group support will mediate greater improvements in patient psychological functioning in both groups but that the effects of group support will be significantly stronger in SG than ECG.


Recruitment information / eligibility

Status Completed
Enrollment 611
Est. completion date October 2015
Est. primary completion date October 2014
Accepts healthy volunteers No
Gender Both
Age group 18 Years and older
Eligibility Inclusion Criteria:

- patient has a primary diagnosis of Stage 0 (Ductal Carcinoma in situ), 1, 2, or 3a breast cancer

- patient has had breast cancer surgery within the last twelve months

- patient and partner married or cohabitating

- patient and partner 18 years of age or older

- patient and partner speak and read English

- patient and partner can provide meaningful informed consent

- patient and partner do not have any chronic physical or cognitive illness that would preclude participation in the group sessions

- couple lives within 2 hour commuting distance to the center from which they are recruited

Exclusion criteria:

- patient is male

Study Design

Allocation: Randomized, Intervention Model: Parallel Assignment, Masking: Open Label, Primary Purpose: Supportive Care


Related Conditions & MeSH terms


Intervention

Behavioral:
Group Counseling
Group counseling

Locations

Country Name City State
United States Bryn Mawr Hospital Bryn Mawr Pennsylvania
United States Christiana Care Health System Newark Delaware
United States Fox Chase Cancer Center Philadelphia Pennsylvania
United States Cooper Health System Voorhees New Jersey
United States Virtua Health System Voorhees New Jersey

Sponsors (8)

Lead Sponsor Collaborator
Fox Chase Cancer Center Abington Memorial Hospital, Albert Einstein College of Medicine of Yeshiva University, Christiana Care Health Services, City University of New York, School of Public Health, National Cancer Institute (NCI), The Cooper Health System, Virtua Health

Country where clinical trial is conducted

United States, 

References & Publications (3)

Manne S, Kashy DA, Siegel S, Myers Virtue S, Heckman C, Ryan D. Unsupportive partner behaviors, social-cognitive processing, and psychological outcomes in couples coping with early stage breast cancer. J Fam Psychol. 2014 Apr;28(2):214-24. doi: 10.1037/a0 — View Citation

Manne SL, Siegel S, Kashy D, Heckman CJ. Cancer-specific Relationship Awareness, Relationship Communication, and Intimacy Among Couples Coping with Early Stage Breast Cancer. J Soc Pers Relat. 2014 May;31(3):314-334. — View Citation

Manne, S. & Ostroff, J. (2011). Couple-focused group intervention for women diagnosed with early stage breast cancer and their partners. In. D. Kissane & M Watson (Eds.), IPOS Academy Handbook of Psychotherapies in Cancer Care. (pp. 129-139). Chichester,

Outcome

Type Measure Description Time frame Safety issue
Primary Mental Health Inventory time of consent/baseline, 1 week post-intervention, 6 months post-intervention, 12 months post-intervention No
Primary Impact of Events Scale-Revised baseline, 1 week post-intervention, 6 mos post-intervention, 12 mos post-intervention No
Primary Well-being Subscale of the Mental Health Inventory (MHI) baseline, 1 wk post-intervention, 6 mos post-intervention, 12 mos post-intervention No
Secondary Mental Outcomes Survey (MOS SF-36) baseline, 1 wk post-intervention, 6 mos post-intervention, 12 mos post-intervention No
Secondary Adherence to Chemotherapy 1 yr follow-up No
Secondary Adherence to Radiation Therapy 1 yr follow-up No
See also
  Status Clinical Trial Phase
Recruiting NCT04681911 - Inetetamab Combined With Pyrotinib and Chemotherapy in the Treatment of HER2 Positive Metastatic Breast Cancer Phase 2
Completed NCT04890327 - Web-based Family History Tool N/A
Terminated NCT04066790 - Pyrotinib or Trastuzumab Plus Nab-paclitaxel as Neoadjuvant Therapy in HER2-positive Breast Cancer Phase 2
Completed NCT03591848 - Pilot Study of a Web-based Decision Aid for Young Women With Breast Cancer, During the Proposal for Preservation of Fertility N/A
Recruiting NCT03954197 - Evaluation of Priming Before in Vitro Maturation for Fertility Preservation in Breast Cancer Patients N/A
Terminated NCT02202746 - A Study to Assess the Safety and Efficacy of the VEGFR-FGFR-PDGFR Inhibitor, Lucitanib, Given to Patients With Metastatic Breast Cancer Phase 2
Active, not recruiting NCT01472094 - The Hurria Older PatiEnts (HOPE) With Breast Cancer Study
Withdrawn NCT06057636 - Hypnosis for Pain in Black Women With Advanced Breast Cancer: A Feasibility Study N/A
Completed NCT06049446 - Combining CEM and Magnetic Seed Localization of Non-Palpable Breast Tumors
Recruiting NCT05560334 - A Single-Arm, Open, Exploratory Clinical Study of Pemigatinib in the Treatment of HER2-negative Advanced Breast Cancer Patients With FGFR Alterations Phase 2
Active, not recruiting NCT05501769 - ARV-471 in Combination With Everolimus for the Treatment of Advanced or Metastatic ER+, HER2- Breast Cancer Phase 1
Recruiting NCT04631835 - Phase I Study of the HS-10352 in Patients With Advanced Breast Cancer Phase 1
Completed NCT04307407 - Exercise in Breast Cancer Survivors N/A
Recruiting NCT03544762 - Correlation of 16α-[18F]Fluoro-17β-estradiol PET Imaging With ESR1 Mutation Phase 3
Terminated NCT02482389 - Study of Preoperative Boost Radiotherapy N/A
Enrolling by invitation NCT00068003 - Harvesting Cells for Experimental Cancer Treatments
Completed NCT00226967 - Stress, Diurnal Cortisol, and Breast Cancer Survival
Recruiting NCT06006390 - CEA Targeting Chimeric Antigen Receptor T Lymphocytes (CAR-T) in the Treatment of CEA Positive Advanced Solid Tumors Phase 1/Phase 2
Recruiting NCT06037954 - A Study of Mental Health Care in People With Cancer N/A
Recruiting NCT06019325 - Rhomboid Intercostal Plane Block on Chronic Pain Incidence and Acute Pain Scores After Mastectomy N/A